To address the human relevance of our findings, we examined the relationship between hepatic CIDEA, CIDEB, CIDEC1 and CIDEC2 expression and the NAFLD progression from normal liver to steatosis and subsequent NASH in human liver biopsies from morbidly obese patients seeking for bariatric surgery. The gene discussed is CIDEB; the disease is metabolic dysfunction-associated steatotic liver disease.